Skip to main content
Psychiatry
ALL Specialities
ALL Specialities
/
Psychiatry
COVID-19 Updates
News
From the Journals
FDA/CDC
Guidelines
Feature
Latest News
News by Conference
News from the FDA/CDC
Perspectives
Commentary
Curbside Consult
Families in Psychiatry
For Residents
From the Editor
Interview
Mental Health Consult
Shrink Rap News
Techiatry
Weighty Issues
Supplements
Reviews
Cases That Test Your Skills
Clinical Neuroscience
Evidence-Based Reviews
Med/Psych Update
Out of the Pipeline
Pearls
Savvy Psychopharmacology
CME
CME Supplements
Medical Education Library
Diseases and Conditions
Addiction Medicine
ADHD
Alzheimer's & Cognition
Anxiety Disorders
Bipolar Disorder
Depression
Eating Disorders
Movement Disorders
Personality Disorders
PTSD
Schizophrenia & Other Psychotic Disorders
Sleep Medicine
Somatic Disorders
Multimedia
Podcasts
Video
Resource Center
Lifestyle
Latest News
Study provides new analysis of isotretinoin and risk for adverse neuropsychiatric outcomes
Publish date:
May 5, 2022
FROM THE BRITISH JOURNAL OF DERMATOLOGY
A version of this article first appeared on
Medscape.com
.
Pages
« first
1
2
Recommended Reading
Mental health risks higher in sexual minorities with acne
MDedge Psychiatry
Acne is linked to higher chances of major depression
MDedge Psychiatry
MDedge Daily News: How smartphones could battle oral cancer
MDedge Psychiatry
Trump administration rule erodes ACA contraceptive mandate
MDedge Psychiatry
No increased risk of psychiatric problems tied to isotretinoin
MDedge Psychiatry
iPLEDGE allows at-home pregnancy tests during pandemic
MDedge Psychiatry
Evidence on spironolactone safety, COVID-19 reassuring for acne patients
MDedge Psychiatry
Daily Recap 6/17
MDedge Psychiatry
Who’s at risk for depression on isotretinoin?
MDedge Psychiatry
Study highlights impact of acne in adult women on quality of life, mental health
MDedge Psychiatry
Mixed Topics
Pediatrics
Neurology
All Specialties